Sign in
4

Changes in Ownership

Silence Therapeutics plc Filed Acc 0001415889-25-000747

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ross Iain Director 2025-01-02 Grant or award · Share Option (Right to Buy) +90,000 90,000 D
Loading xslF345X05/form4-01062025_040111.xml…